Evidence map›Paper›PMID 38827151›Full record

ArticleFrontiers in microbiology2024

Evaluation of the mechanistic basis for the antibacterial activity of ursolic acid against

Guanhui Liu, Peng Qin, Xinying Cheng, Lifei Wu, Wentao Zhao, Wei Gao

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Investigating the role of cytochromeRSC medicinal chemistry · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Antimicrobial effects of compound Huangbai liquid onAmerican journal of translational research · 2026
    Article
  7. Review
  8. Article
  9. Antimicrobial Activity ofInternational journal of molecular sciences · 2024
    Article
  10. Review
  11. Effect of anti-biofilm peptideFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guanhui LiuSchool of Life Sciences and Food Engineering, Hebei University of Engineering, Handan, China.
Peng QinChenguang Biotechnology Group Handan Co., Ltd., Handan, China.
Xinying ChengChenguang Biotechnology Group Handan Co., Ltd., Handan, China.
Lifei WuHebei Plant Extraction Innovation Center Co., Ltd., Handan, China.
Wentao ZhaoSchool of Life Sciences and Food Engineering, Hebei University of Engineering, Handan, China.
Wei GaoHebei Plant Extraction Innovation Center Co., Ltd., Handan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antibiotics are generally regarded as the first choice approach to treat dairy mastitis, targeting the public health problems associated with the food safety and the emergence of antibioticresistant bacteria. The objective of the study was to evaluate the antibacterial efficacy of ursolic acid (UA) when used to treat

Indexed as

antibacterial activitydairy mastitisRosmarinus officinalis L.Staphylococcus aureussynergistic effectursolic acid

Identifiers

PMID38827151
PMCPMC11140147

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.